IP Library Granted Patent US 12,209,253
Granted Patent B2
US 12,209,253 · App. 15/352,289 · Granted Jan 28, 2025

Development of spinal cord on a microfluidic chip

Inventors: S.Jordan Kerns (Reading, MA); Norman Wen (West Roxbury, MA); Carol Lucchesi (Westwood, MA); Christopher Hinojosa (Cambridge, MA); Jacob Fraser (Somerville, MA); Geraldine Hamilton (Cambridge, MA); Gad Vatine (Los Angeles, CA); Samuel Sances (Santa Monica, CA); Clive Svendsen (Pacific Palisades, CA); Daniel Levner, II (Brookline, MA); Dhruv Sareen (Porter Ranch, CA)
Assignees: EMULATE, INC.; CEDARS-SINAI MEDICAL CENTER
C12N5/0068B01L3/502715C12M23/16C12M25/02C12N5/0623C12N5/069B01L2300/044B01L2300/0858B01L2300/123C12N2502/088C12N2531/00C12N2535/10C12N2539/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,209,253
App. No.
15/352,289
Granted
Jan 28, 2025
Kind
B2
Abstract

The invention relates to culturing brain endothelial cells, and optionally astrocytes and neurons in a fluidic device under conditions whereby the cells mimic the structure and function of the blood brain barrier. Culture of such cells in a microfluidic device, whether alone or in combination with other cells, drives maturation and/or differentiation further than existing systems.

Claims (64)

1. A method of culturing cells, comprising:

a) providing a microfluidic device comprising a membrane, said membrane comprising a first surface and a second surface;

b) seeding human stem-cell derived brain cells on said first surface so as to create seeded stem-cell derived brain cells and seeding brain microvascular endothelial cells on said second surface so as to create seeded brain microvascular endothelial cells;

c) exposing said seeded stem-cell derived brain cells and said seeded brain microvascular endothelial cells to a flow of culture media for a period of time;

d) culturing said seeded stem-cell derived brain cells to produce cultured stem-cell derived brain cells, and culturing said seeded brain microvascular endothelial cells to produce cultured brain microvascular endothelial cells such that a portion of said cultured stem-cell derived brain cells exhibit periodic spontaneous bursts of calcium transient activity indicative of spinal cord development; and

e) detecting an increased frequency of calcium transients compared to when culturing said stem-cell derived brain cells without said brain microvascular endothelial cells.

2. The method of claim 1 , wherein said cultured stem-cell derived brain cells are cultured for more than twenty days.

3. The method of claim 1 , wherein said cultured stem-cell derived brain cells are cultured for more than twenty-five days.

4. The method of claim 1 , wherein the portion of said cultured stem-cell derived brain cells exhibiting periodic spontaneous bursts of calcium transient activity is at least 20%.

5. The method of claim 1 , wherein the portion of said cultured stem-cell derived brain cells exhibiting periodic spontaneous bursts of calcium transient activity is at least 30%.

6. The method of claim 1 , wherein said microfluidic device comprises a microfluidic channel in fluidic communication with said second surface of said membrane, wherein said microfluidic channel comprises side walls and a surface that is parallel to said membrane, and wherein said cultured brain microvascular endothelial cells grow on the parallel surface and side walls of the microfluidic channel so as to form a lumen.

7. The method of claim 6 , wherein said cultured brain microvascular endothelial cells express the marker Glut 1.

8. The method of claim 1 , wherein said seeding of said stem-cell derived brain cells comprises seeding on wet laminin.

9. The method of claim 1 , wherein said stem-cell derived brain cells comprise induced motor neuron progenitor cells.

10. The method of claim 1 , wherein said microfluidic device comprises a first microfluidic channel in fluidic communication with said first surface of said membrane and a second microfluidic channel in fluidic communication with said second surface of said membrane, said first and second microfluidic channels each comprising a surface that is parallel to said membrane, and each comprising side walls.

11. The method of claim 10 , wherein said microfluidic device further comprises at least one inlet port and at least one outlet port, and said culture media enters said inlet port and exits said outlet port.

12. The method of claim 10 , wherein said first and second microfluidic channels comprise polydimethylsiloxane.

13. The method of claim 1 , wherein said stem-cell derived brain cells exhibit greater calcium transient activity in said microfluidic device than when cultured on 96-well plates.

14. A method of culturing cells, comprising:

a) providing a microfluidic device comprising a membrane, said membrane comprising a first surface and a second surface;

b) seeding induced human motor neuron progenitor cells on said first surface so as to create seeded induced motor neuron progenitor cells and seeding brain microvascular endothelial cells on said second surface so as to create seeded brain microvascular endothelial cells;

c) exposing said seeded induced motor neuron progenitor cells and said seeded brain microvascular endothelial cells to a flow of culture media for a period of time;

d) culturing said seeded induced motor neuron progenitor cells to produce cultured induced motor neuron progenitor cells that differentiate into motor neurons, and culturing said seeded brain microvascular endothelial to produce cultured brain microvascular endothelial cells such that a portion of said motor neurons exhibit periodic spontaneous bursts of calcium transient activity indicative of spinal cord development; and

e) detecting an increased frequency of calcium transients compared to when culturing said motor neurons without said brain microvascular endothelial cells.

15. The method of claim 14 , wherein said cultured induced motor neuron progenitor cells are cultured for more than twenty days.

16. The method of claim 14 , wherein said cultured induced motor neuron progenitor cells are cultured for more than twenty-five days.

17. The method of claim 14 , wherein the portion of said cultured induced motor neuron progenitor cells exhibiting periodic spontaneous bursts of calcium transient activity is at least 20%.

18. The method of claim 14 , wherein the portion of said cultured induced motor neuron progenitor cells exhibiting periodic spontaneous bursts of calcium transient activity is at least 30%.

19. The method of claim 14 , wherein said induced motor neuron progenitor cells are derived from induced pluripotent stem cells from a human patient diagnosed with a CNS disorder.

20. The method of claim 14 , wherein said flow promotes differentiation of said induced motor neuron progenitor cells.

21. The method of claim 14 , wherein said neurons exhibit a more mature electrophysiology as evidenced by more pronounced currents as compared to the same neurons cultured in a static culture.

22. The method of claim 14 , wherein said motor neurons exhibit greater calcium transient activity in said microfluidic device than when cultured on 96-well plates.

23. A method of culturing cells, comprising:

a) providing a microfluidic device comprising a membrane, said membrane comprising a first surface and a bottom second surface;

b) seeding induced human motor neuron progenitor cells on said first surface so as to create seeded induced motor neuron progenitor cells and seeding brain microvascular endothelial cells on said bottom second surface so as to create seeded brain microvascular endothelial cells;

c) exposing said seeded induced motor neuron progenitor cells and said seeded brain microvascular endothelial cells to a flow of culture media for a period of time;

d) culturing said seeded induced motor neuron progenitor cells to produce cultured induced motor neuron progenitor cells and culturing said seeded brain microvascular endothelial to produce cultured brain microvascular endothelial cells such that a portion of said cultured induced motor neuron progenitor cells differentiate to motor neurons and a portion of said motor neurons exhibit complex and repetitive bursts of neuronal activity indicative of neuronal networks being established in the microfluidic device; and

e) detecting greater neuronal activity compared to when culturing said motor neurons without said brain microvascular endothelial cells.

24. The method of claim 23 , wherein said cultured induced motor neuron progenitor cells are cultured for more than twelve days.

25. The method of claim 23 , wherein said motor neurons exhibit greater neuronal activity in said microfluidic device than when cultured on 96-well plates.

26. A method of culturing cells, comprising:

a) providing a microfluidic device comprising a membrane, said membrane comprising a first surface and a second surface;

b) seeding human stem-cell derived brain cells on said first surface so as to create seeded stem-cell derived brain cells and seeding brain microvascular endothelial cells on said second surface so as to create seeded brain microvascular endothelial cells;

c) exposing said seeded stem-cell derived brain cells and said seeded brain microvascular endothelial cells to a flow of culture media for a period of time;

d) culturing said seeded stem-cell derived brain cells to produce cultured stem-cell derived brain cells, and culturing said seeded brain microvascular endothelial cells to produce cultured brain microvascular endothelial cells such that a portion of said cultured stem-cell derived brain cells exhibit periodic spontaneous bursts of calcium transient activity indicative of spinal cord development; and

e) detecting a more mature electrophysiological phenotype compared to stem-cell derived brain cells cultured without said brain microvascular endothelial cells.

27. The method of claim 26 , wherein a more mature electrophysiological phenotype comprises increased frequency of calcium transients.

28. The method of claim 26 , wherein a more mature electrophysiological phenotype comprises spontaneous action potential train spikes.

29. The method of claim 26 , wherein a more mature electrophysiological phenotype comprises at least double current amplitude.

30. A method of culturing cells, comprising:

a) providing a microfluidic device comprising a membrane, said membrane comprising a first surface and a second surface;

b) seeding induced human motor neuron progenitor cells on said first surface so as to create seeded induced motor neuron progenitor cells and seeding brain microvascular endothelial cells on said second surface so as to create seeded brain microvascular endothelial cells;

c) exposing said seeded induced motor neuron progenitor cells and said seeded brain microvascular endothelial cells to a flow of culture media for a period of time;

d) culturing said seeded induced motor neuron progenitor cells to produce cultured induced motor neuron progenitor cells that differentiate into motor neurons, and culturing said seeded brain microvascular endothelial to produce cultured brain microvascular endothelial cells such that a portion of said motor neurons exhibit periodic spontaneous bursts of calcium transient activity indicative of spinal cord development; and

e) detecting a more mature electrophysiological phenotype compared to said motor neurons cultured without said brain microvascular endothelial cells.

31. The method of claim 30 , wherein a more mature electrophysiological phenotype comprises increased frequency of calcium transients.

32. The method of claim 30 , wherein a more mature electrophysiological phenotype comprises spontaneous action potential train spikes.

33. The method of claim 30 , wherein a more mature electrophysiological phenotype comprises at least double current amplitude.

34. A method of culturing cells, comprising:

a) providing a microfluidic device comprising a membrane, said membrane comprising a first surface and a second surface;

b) seeding induced human motor neuron progenitor cells on said first surface so as to create seeded induced motor neuron progenitor cells and seeding brain microvascular endothelial cells on said second surface so as to create seeded brain microvascular endothelial cells;

c) exposing said seeded induced motor neuron progenitor cells and said seeded brain microvascular endothelial cells to a flow of culture media for a period of time;

d) culturing said seeded induced motor neuron progenitor cells to produce cultured induced motor neuron progenitor cells and culturing said seeded brain microvascular endothelial to produce cultured brain microvascular endothelial cells such that a portion of said cultured induced motor neuron progenitor cells differentiate to motor neurons and a portion of said motor neurons exhibit complex and repetitive bursts of neuronal activity indicative of neuronal networks being established in the microfluidic device; and

e) detecting greater neuron activity indicative of neuronal networks compared to when culturing said motor neurons without said brain microvascular endothelial cells, wherein said detecting is done by at least one of patch clamp measurements, extracellular electrophysiology measurements, imaging using calcium-sensitive dyes or proteins, or imaging using voltage-sensitive dyes or proteins.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Oct 28, 2025
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: EMULATE, INC.
Reel/Frame 073365/0249 →
RELEASE OF SECURITY INTEREST Recorded Oct 20, 2025
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: EMULATE, INC.
Reel/Frame 073116/0888 →
SECURITY AGREEMENT Recorded Aug 25, 2021
From: EMULATE, INC.
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 057311/0564 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2018
From: KERNS, S. JORDAN; WEN, NORMAN; LUCCHESI, CAROL; HINOJOSA, CHRISTOPHER; FRASER, JACOB; HAMILTON, GERALDINE; VATINE, GAD; SANCES, SAMUEL; SVENDSEN, CLIVE; LEVNER, DANIEL; SAREEN, DHRUV
To: EMULATE, INC.; CEDARS-SINAI MEDICAL CENTER
Reel/Frame 045602/0850 →
Continuity (3)
Continuation PCTUS2016057724 · Oct 19, 2016
Provisional Application 62380780 · Aug 29, 2016
Related Publication 20180057788A1 · Mar 1, 2018
References Cited (23)
US 8647861B2 · Ingber et al. · 2014 [cited by applicant]
US 20080044847A1 · Shusta · 2008 [cited by examiner]
US 20140142370A1 · Wong · 2014 [cited by examiner]
WO WO2015138032A2 · 2015 [cited by examiner]
Rosenberg et al (Cold Spring Harb Perspect Biol 3:a004259, 1-13, 2011). [cited by examiner]
Zilio et al (Biomed Microdevices 16: 107-114, Sep. 15, 2014). [cited by examiner]
Dhumpa et al (Anal Chim Acta 743: 9-18, 2012). [cited by examiner]
Gross et al, (J Neurol Sc 252: 135-143, 2007). [cited by examiner]
Gel—Wikipedia, downloaded from https://en.wikipedia.org/wiki/Gel on Sep. 14, 2018. [cited by examiner]
Kwasny et al (Curr Protoc Pharmacol : 50: 13A.8.1-13A.8.23 (1-27), 2010). [cited by examiner]
Wang et al (Lab Chip 9: 644-652, 2009). [cited by examiner]
Nenni et al. (Front Physiol 10: 1-13, 2019). [cited by examiner]
Sances et al. (Stem Cell Reports 10: 1222-1236, 2018). [cited by examiner]
Kelamangalath et al. (Mol Pharmacol 79: 1061-1071, 2011). [cited by examiner]
Yang et al (Br Res Bull 84: 1-7, 2011). [cited by examiner]
Abbott et al (Conf Abstract: Pharm Tox BBB: 1-3, Feb. 2010). [cited by examiner]
Naik et al (J Pharm Sc 101: 1337-1354, 2012). [cited by examiner]
Douville, N. J. et al. (2010) “Fabrication of Two-Layered Channel System with Embedded Electrodes to Measure Resistance Across Epithelial and Endothelial Barriers,” [cited by applicant]
Ebert, A. D. et al. (2013) “EZ spheres: A stable and expandable culture system for the generation of pre-rosette. Multipotent stem cells from human ESCs and iPSCs,” [cited by applicant]
Lippmann, E. S. et al. (2012) “Human Blood-Brain Barrier Endothelial Cells Derived from Pluripotent Stem Cells,” [cited by applicant]
Okita, K. et al. (2011) “A more efficient method to generate integration-free human iPS cells,” [cited by applicant]
Sareen, D. et al. (2014) “Human neural progenitor cells generated from induced pluripotent stem cells can survive, migrate, and integrate in the rodent spinal cord,” [cited by applicant]
Sareen, D. et al. (2013) “Targeting RNA foci in iPSC-derived motor neurons from ALS patients with C9ORF72 repeat expansion,” [cited by applicant]